Molecular Templates, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity (Deficit)

Consolidated Statements of Stockholders' Equity (Deficit) (USD $) In Thousands, except Share data	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Balances, value at Dec. 31, 2011	$ 4,483us-gaap_StockholdersEquity	$ 49	$ 256,563	$ (1)	$ (252,128)
Balances, shares at Dec. 31, 2011		49,128,475
Issuance of common stock to certain investors, net of issuance costs of $0.4 million, value	12,323	2	12,321
Issuance of common stock to certain investors, net of issuance costs of $0.4 million, shares		2,022,144
Exercise of warrants to purchase common stock, value	8,849	5	8,844
Exercise of warrants to purchase common stock, shares		4,727,331
Issuance of common stock pursuant to stock plans, value	738		738
Issuance of common stock pursuant to stock plans, shares		553,257
Stock-based compensation	3,010		3,010
Reclassification of fair value of warrants exercised from liability to equity	27,867		27,867
Change in unrealized gain (loss) on marketable securities	12			12
Net loss	(71,135)us-gaap_NetIncomeLoss				(71,135)
Balances, value at Dec. 31, 2012	(13,853)us-gaap_StockholdersEquity	56	309,343	11	(323,263)
Balances, shares at Dec. 31, 2012		56,431,207
Exercise of warrants to purchase common stock, value	1,882	3	1,879
Exercise of warrants to purchase common stock, shares		2,488,518
Issuance of common stock pursuant to stock plans, value	510		510
Issuance of common stock pursuant to stock plans, shares		312,886
Stock-based compensation	4,922		4,922
Reclassification of fair value of warrants exercised from liability to equity	11,462		11,462
Change in unrealized gain (loss) on marketable securities	17			17
Net loss	(28,415)us-gaap_NetIncomeLoss				(28,415)
Balances, value at Dec. 31, 2013	(23,475)us-gaap_StockholdersEquity	59	328,116	28	(351,678)
Balances, shares at Dec. 31, 2013	59,232,611us-gaap_CommonStockSharesOutstanding	59,232,611
Exercise of warrants to purchase common stock, value	4,834	3	4,831
Exercise of warrants to purchase common stock, shares		3,437,348
Issuance of common stock pursuant to stock plans, value	686	1	685
Issuance of common stock pursuant to stock plans, shares		228,274
Stock-based compensation	5,488		5,488
Reclassification of fair value of warrants exercised from liability to equity	10,116		10,116
Change in unrealized gain (loss) on marketable securities	(41)			(41)
Net loss	(21,584)us-gaap_NetIncomeLoss				(21,584)
Balances, value at Dec. 31, 2014	$ (23,976)us-gaap_StockholdersEquity	$ 63	$ 349,236	$ (13)	$ (373,262)
Balances, shares at Dec. 31, 2014	62,898,233us-gaap_CommonStockSharesOutstanding	62,898,233